30 results
8-K
EX-10.1
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies
8-K
EX-14.1
3pwd2amxz5 8cat4
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
S-3ASR
EX-4.4
e1xn801
14 Sep 23
Automatic shelf registration
5:28pm
PRE 14A
4a5f6vk2bgjou58 8kk
18 Apr 23
Preliminary proxy
4:05pm
S-3
EX-4.4
r5kvjcqfkbirr5 8s
1 Jun 22
Shelf registration
4:06pm
DEF 14A
u2ymzf0 58
28 Apr 22
Definitive proxy
4:44pm
10-K
xfcp18azh3zv 5kvp
7 Mar 22
Annual report
7:36am
10-Q
cckdknwl
10 Aug 21
Quarterly report
5:26pm